GGrantIndex
Sort

24,827 grants matching epilepsy

Device-Independent Acquisition and Real Time Spatiotemporal Analysis of Clinical Electrophysiology Data

$1,157,210
Matti Hamalainen · Massachusetts General Hospital · U01 · FY2018 · EB

Device-Independent Acquisition and Real Time Spatiotemporal Analysis of Clinical Electrophysiology Data

$1,157,210
Matti Hamalainen · Massachusetts General Hospital · U01 · FY2019 · EB

Drug development for tuberous sclerosis complex and other pediatric epileptogenic diseases using neurovascular and cardiac microphysiological models

$1,156,801
John Peter Wikswo · Vanderbilt University · UH3 · FY2019 · TR

Bioimaging and Intervention in Localization-Related Epilepsy

$1,155,113
James S Duncan · Yale University · R01 · FY2009 · EB

Cellular Mechanisms Of Xenobiotic Transport

$1,153,051
David Miller · National Institute Of Environmental Health Sciences · ZIA · FY2013 · ES

Structural Dynamics of Presynaptic Membrane Fusion

$1,152,973
Lukas K Tamm · University Of Virginia · P01 · FY2011 · GM

The International epilepsy electrophysiology database

$1,152,456
Brian Litt · University Of Pennsylvania · U24 · FY2010 · NS

Epilepsy Research Program

$1,151,580
Stanford University · P50 · FY2004 · NS

Center for Advanced Metabolic Imaging in Precision Medicine (CAMIPM)

$1,151,186
Ravinder Reddy · University Of Pennsylvania · P41 · FY2024 · EB

Role of Neurotrophins in the Development of the Mammalian Nervous System

$1,150,610
Lino Tessarollo · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA

Drug development for tuberous sclerosis complex and other pediatric epileptogenic diseases using neurovascular and cardiac microphysiological models

$1,149,938
John Peter Wikswo · Vanderbilt University · UH3 · FY2020 · TR

POST-TRAUMATIC EPILEPSY CENTER WITHOUT WALLS

$1,149,640
Trustees Of The University Of Pennsylvania, The · · FY2025 · Defense Health Agency

Drug development for tuberous sclerosis complex and other pediatric epileptogenic diseases using neurovascular and cardiac microphysiological models

$1,149,180
John Peter Wikswo · Vanderbilt University · UH3 · FY2021 · TR

The Epilepsy Bioinformatics Study for Antiepileptogenic Therapy (EpiBioS4Rx) Project 3: Biomarkers of Human Epileptogenesis After Traumatic Brain Injury

$1,147,518
Paul M Vespa · University Of Southern California · U54 · FY2021 · NS

Brain Glycogen - Metabolism, Mechanisms, and Therapeutic Potential

$1,147,500
Matthew S. Gentry · University Of Kentucky · R35 · FY2022 · NS

Brain Glycogen - Metabolism, Mechanisms, and Therapeutic Potential

$1,147,500
Matthew S. Gentry · University Of Kentucky · R35 · FY2021 · NS

Neuronal mechanisms of human episodic memory

$1,146,695
Ueli Rutishauser · Cedars-Sinai Medical Center · U01 · FY2018 · NS

Drug development for tuberous sclerosis complex and other pediatric epileptogenic diseases using neurovascular and cardiac microphysiological models

$1,146,280
John Peter Wikswo · Vanderbilt University · UG3 · FY2017 · TR

Homeostatic Stabilization of Neural Function in Health and Disease

$1,145,783
Graeme W Davis · University Of California, San Francisco · R35 · FY2024 · NS

Cellular Mechanisms Of Xenobiotic Transport

$1,144,364
David Miller · National Institute Of Environmental Health Sciences · ZIA · FY2012 · ES

NHGRI/DIR Genomics Core

$1,144,148
Settara Chandrasekharappa · National Human Genome Research Institute · ZIC · FY2025 · HG

Dissection of spatiotemporal activity from large-scale, multi-modal, multi-resolution hippocampal-neocortical recordings.

$1,144,125
Zhe Sage Chen · New York University School Of Medicine · RF1 · FY2022 · DA

Drug development for tuberous sclerosis complex and other pediatric epileptogenic diseases using neurovascular and cardiac microphysiological models

$1,142,940
John Peter Wikswo · Vanderbilt University · UH3 · FY2020 · TR

Neuronal mechanisms of human episodic memory

$1,141,201
Ueli Rutishauser · Cedars-Sinai Medical Center · U01 · FY2019 · NS

Structural Dynamics of Presynaptic Membrane Fusion

$1,140,428
Lukas K Tamm · University Of Virginia · P01 · FY2015 · GM